2020 News November 16, 2020 Nymox Provides Update on

New Post Public Reply Private Reply Replies (0) Message Board
znewcar1
263
2020 News
November 16, 2020
Nymox Provides Update on Regulatory Filing Activities
Nymox Pharmaceutical Corporation is pleased to provide a current update on the regulatory filing status for Fexapotide Triflutate (FT), Nymox's first in class lead product for the treatment of benign prostatic hyperplasia (BPH). Substantial progress has been made and there are no material changes to the content of the planned applications.

Download
August 12, 2020
Nymox Announces $9 Million Registered Direct Offering
Nymox Pharmaceutical Corporation today announced it has entered into definitive agreements with institutional and accredited investors for the purchase and sale of shares of its common stock.

Download
July 28, 2020
NYMOX Provides Current Update on Key Company Developments
Nymox Pharmaceutical Corporation is pleased to report current updates on the Company's most important ongoing developments.

Download
June 19, 2020
Nymox Announces Updates in Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
Nymox Pharmaceutical Corporation is very pleased to report that key steps in its regulatory submission preparations have been completed and the project is firmly on-track.

Download
April 21, 2020
Nymox Announces Important New Patent Developments
Nymox Pharmaceutical Corporation is pleased to announce the recent allowances of 4 new different US and international patents concerning the Company's prostate enlargement and prostate cancer treatments.

Download
February 24, 2020
Nymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology
Nymox Pharmaceutical Corporation is pleased to announce that a new peer review report was published today in the World Journal of Urology, documenting the successful long-term clinical trial results after Fexapotide Triflutate treatment for early stage prostate cancer.

Download
February 6, 2020
Nymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
Nymox Pharmaceutical Corporation is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC to the position of Nymox Vice President of Quality and Regulatory Affairs. Dr Thomson is an authority in the field of Quality Assurance and Control in the chemical and pharmaceutical industries.

Download
January 28, 2020
Nymox Provides Update on Current Corporate Activities and Milestones
Nymox Pharmaceutical Corporation is pleased to provide a current January 2020 update on several important corporate activities and achievements since the last update in October 2019.

Download
January 6, 2020
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in Urology
Nymox Pharmaceutical Corporation is pleased to report a new peer review research report has been published on experimental studies of the Company's Fexapotide Triflutate treatment for prostate enlargement (BPH) and low grade prostate cancer. The article is entitled "Fexapotide triflutate induces selective prostate glandular pharmaco-ablation in the rat" and it is published in Research and Reports in Urology.

Nymox Pharmaceutical Corp. (NYMX) Stock Research Links

NYMX Board Company Profile Buy Rating Time & Sales News Filings Financials
The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.

I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lyntris Advances KSAT Hyperion Satellite Program Milestone

Updated Category News Views 0

Lyntris and KSAT: A Technological Feat in Space Connectivity Well, if it ain't Lyntris back in the headlines again, pushing the envelope on space connectivity. If you're keeping tabs on the space tech space, there's a cracker of a development brewing. Lyntris Inc. (NYSE: LYNX) just checked off a crucial box in their playbook—the Critical Design Review, or CDR for those...

Continue Reading
Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 3

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Rodeo Dental Gears Up for National Growth Surge

Updated Category News Views 2

Rodeo Dental's Leadership Shuffle When you're talking about upping the ante in the dental world, you can't ignore the recent shake-up at Rodeo Dental & Orthodontics. They've decided to retool their corner office lineup, and this is where the folks in suits meet the folks with the steady hands in teeth. Co-Founder Dr. Saam Zarrabi is stepping into an Executive Chairman...

Continue Reading
Brennan Elevates Tim Donohue to Key Leadership Role

Updated Category News Views 2

Veteran's Sway in the Net Lease Arena Out in Rosemont, Illinois, Brennan Investment Group is moving in on a strategic play by bumping Tim Donohue up to Senior Vice President, Net Lease. It's a title that speaks volumes if you ask me, especially when you're armed with four decades of commercial real estate heft. These folks don't take promotions lightly, not in the world...

Continue Reading
Pentair Faces Class Action Over Fraud Allegations

Updated Category News Views 1

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Continue Reading
Eluvio's Game-Changer: AI Integrated Direct to Stream

Updated Category News Views 3

A groundbreaking change is thrust upon the video streaming landscape, disrupting traditional workflows. Eluvio, with its Universal & Dynamic Video Intelligence Architecture, is not just tweaking the formula; it's setting a brand-new standard. Their innovations were on full display at the IBC Show 2026 in Amsterdam, and believe me, they're redefining how we think about...

Continue Reading
Post-Facial Care: Extend Benefits Beyond the Spa

Updated Category News Views 1

The Day After a Facial Is Just as Crucial If you’re thinking a facial ends when you walk out of the spa, you’re dead wrong. Valen Perez, the driving force behind Picture Perfect Esthetics LLC in Fayetteville, NC, breaks it down in HelloNation: the glow-wielding magic of a facial needs the right follow-up to really shine. You spend that cash on a pro facial, but...

Continue Reading
Hello Group Posts Q2 Earnings with Mixed Signals

Updated Category News Views 4

Q2 Revenue Slump Amid Profit Recovery No sugarcoating it, revenue numbers for Hello Group Inc. (NASDAQ:MOMO) are less than stellar for the second quarter of 2026. Net revenues fell 5.1% year-over-year to RMB2,486.0 million (about $366.4 million). Not exactly what you want to see in a growth-oriented tech company. However, what’s really worth your attention is the net...

Continue Reading
Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

Updated Category News Views 1

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

Continue Reading
Mind With Heart Robotics Eyes European Market Surge

Updated Category News Views 4

A New Play in Robotics Unfolds Just when you think you've seen it all, here comes Mind With Heart Robotics dropping their AnAn panda robot onto the European stage at IFA Berlin 2026. It's a classic story in the making—an award-winning gadget making noise in the artificial intelligence realm, now eyeing European soil. You could hear the buzz from Berlin to Brussels about...

Continue Reading

Top 5 Most Recently Viewed Articles

Castellum, Inc. Reports Significant Growth in Revenue for Q3

Updated Category News Views 40

Castellum, Inc. Achieves Notable Revenue Growth in the Third Quarter Castellum, Inc. is making waves as it announces its financial results, highlighting a sequential increase in revenue for the third quarter. With a focus on cybersecurity, electronic warfare, and software services tailored for the federal government, Castellum has reported remarkable financial performance...

Continue Reading
Spar Nord Bank's Strategic Share Buybacks: Weekly Update

Updated Category News Views 126

Overview of Spar Nord Bank's Share Buyback Program Spar Nord Bank is actively implementing its share buyback program, which is designed to boost shareholder value and strengthen its capital structure. This initiative was first announced with a budget of up to DKK 500 million, enabling the bank to make strategic purchases in the open market. Details of Recent Transactions...

Continue Reading
Select Medical Partners with Ballad Health for New Hospital

Updated Category News Views 353

Select Medical Announces Partnership with Ballad Health Select Medical Corporation has recently taken a major step in patient care by signing a membership interest purchase agreement with Ballad Health. This strategic collaboration aims to jointly operate Select Specialty Hospital – Tri-Cities, a facility dedicated to critical illness recovery. The hospital will be...

Continue Reading
Pearl Meyer Strengthens Technology Compensation with New MD

Updated Category News Views 122

Pearl Meyer Expands Its Technology Executive Compensation Team Pearl Meyer has recently enhanced its executive compensation practice in the technology sector by adding Will Cockle to its team as a managing director. With a robust background in advising boards and management teams at various high-growth organizations, Cockle is set to contribute significantly to Pearl...

Continue Reading
Jim Foley Takes Helm as President of Zoom Drain Franchise

Updated Category News Views 349

Zoom Drain Welcomes Jim Foley as New Brand President Zoom Drain has recently announced the appointment of Jim Foley as the new Brand President. With over two decades of expertise under his belt, Foley will focus on enhancing and expanding Zoom Drain's franchise presence nationwide. His leadership is expected to play a pivotal role in overseeing various core areas,...

Continue Reading